Financial Performance - For the year ended December 31, 2022, the revenue was RMB 43,139.4 million, an increase of 9.6% compared to 2021[2] - The profit attributable to shareholders for the year ended December 31, 2022, was RMB 1,855.1 million, a decrease of 29.0% from 2021[2] - Basic earnings per share for the year ended December 31, 2022, were RMB 0.42, down 31.1% from 2021[4] - Gross profit for the year ended December 31, 2022, was RMB 4,275.3 million, down from RMB 5,530.6 million in 2021[3] - Operating profit for the year ended December 31, 2022, was RMB 2,718.1 million, compared to RMB 3,540.8 million in 2021[3] - Total comprehensive income for the year ended December 31, 2022, was RMB 1,889.3 million, down from RMB 2,605.8 million in 2021[4] - The total profit before tax for the group was RMB 2,203,483,000, indicating a strong financial performance[24] - The company reported a pre-tax profit of RMB 2,203,483 thousand for 2022, down 31.1% from RMB 3,198,254 thousand in 2021[26] - Net profit for the year ended December 31, 2022, was RMB 1,859.5 million, a decrease of RMB 736.9 million or 28.4% compared to RMB 2,596.4 million for the year ended December 31, 2021[108] Dividends - The board proposed a final dividend of RMB 0.9 per share, totaling RMB 39,817,000, subject to shareholder approval[2] - The company declared a final dividend of RMB 0.9 per share for the year ended December 31, 2022, totaling RMB 39,817,000, subject to shareholder approval[35] - The final dividend distribution ratio is based on the 2022 operating performance, recent trends in China's economic development, and future development needs, with a minimum of 30% of the annual distributable profit for 2022[123] Assets and Liabilities - Non-current assets as of December 31, 2022, amounted to RMB 32,713.8 million, an increase from RMB 24,634.1 million in 2021[5] - Current liabilities as of December 31, 2022, were RMB 25,047.1 million, compared to RMB 16,840.5 million in 2021[6] - Total equity attributable to owners of the company as of December 31, 2022, was RMB 12,110.4 million, up from RMB 10,967.8 million in 2021[6] - The group’s total assets, including interests in joint ventures and associates, amounted to RMB 44,047,467,000, demonstrating a solid asset base[24] - The total liabilities reported were RMB 30,834,407,000, indicating a manageable debt level relative to assets[24] - Total bank and other loans reached RMB 20,228,673,000 as of December 31, 2022, compared to RMB 13,586,680,000 as of December 31, 2021, marking an increase of about 48.6%[54] Revenue Segments - The total revenue for the group reached RMB 45,136,474,000, with significant contributions from the coking and coking products segment at RMB 18,138,685,000 and fine chemical products at RMB 15,657,069,000[24] - Revenue from the coking and coking products segment increased by RMB 467.6 million or 2.9% to RMB 16,368.4 million for the year ended December 31, 2022[93] - Revenue from the fine chemicals segment rose by RMB 1,911.5 million or 14.1% to RMB 15,430.3 million for the year ended December 31, 2022[93] - The trading segment reported revenue of RMB 11,223,815,000, contributing to the overall performance of the group[24] - The operating management segment generated revenue of RMB 62,035,000, reflecting its role in providing management services to third-party factories[24] Cash Flow and Investments - Cash generated from operating activities decreased to approximately RMB 3,163.7 million for the year ended December 31, 2022, down from approximately RMB 4,205.7 million for the year ended December 31, 2021, mainly due to reduced profits[111] - Cash used in investing activities increased from approximately RMB 5,127.1 million for the year ended December 31, 2021, to approximately RMB 9,180.6 million for the year ended December 31, 2022, mainly due to payments for acquisitions and increased capital expenditures[112] Operational Highlights - The company reported a total production/processing volume of approximately 10.6 million tons of coke in 2022, a decrease from 11.0 million tons in 2021[66] - The annual production/processing volume of fine chemical products decreased from approximately 3.86 million tons in 2021 to about 3.64 million tons in 2022[66] - The company produced 384.2 thousand tons of caprolactam and 3.94 million cubic meters of hydrogen energy products in 2022[66] Corporate Governance - The company has established a high standard of corporate governance to enhance shareholder interests and ensure compliance with all mandatory provisions of the corporate governance code[118] - The audit committee reviewed the audited consolidated financial statements for the year ending December 31, 2022, ensuring compliance with accounting principles and internal controls[122] Future Outlook - The company anticipates a rebound in the Chinese economy and will continue to monitor the situation's impact on operations and production[89] - The company plans to continue expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[24]
中国旭阳集团(01907) - 2022 - 年度业绩